UY29115A1 - Un procedimiento para fabricar compuestos enantiomericos del imidazol - Google Patents
Un procedimiento para fabricar compuestos enantiomericos del imidazolInfo
- Publication number
- UY29115A1 UY29115A1 UY29115A UY29115A UY29115A1 UY 29115 A1 UY29115 A1 UY 29115A1 UY 29115 A UY29115 A UY 29115A UY 29115 A UY29115 A UY 29115A UY 29115 A1 UY29115 A1 UY 29115A1
- Authority
- UY
- Uruguay
- Prior art keywords
- imidazol
- procedure
- manufacturing
- enantiomeric compounds
- sertaconazole mononitrate
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 abstract 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
- UEKUFHQHXAAMLQ-UHFFFAOYSA-N 1-imidazol-1-ylethanol Chemical compound CC(O)N1C=CN=C1 UEKUFHQHXAAMLQ-UHFFFAOYSA-N 0.000 abstract 1
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 abstract 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 229910017604 nitric acid Inorganic materials 0.000 abstract 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical class CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 abstract 1
- 238000006276 transfer reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200402184A ES2249992B1 (es) | 2004-09-13 | 2004-09-13 | Un procedimiento para fabricar compuestos enantiomericos del imidazol. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY29115A1 true UY29115A1 (es) | 2005-11-30 |
Family
ID=35614444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY29115A UY29115A1 (es) | 2004-09-13 | 2005-09-13 | Un procedimiento para fabricar compuestos enantiomericos del imidazol |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7626038B2 (https=) |
| EP (1) | EP1794152B1 (https=) |
| JP (1) | JP5048500B2 (https=) |
| KR (1) | KR100903922B1 (https=) |
| CN (1) | CN101023077B (https=) |
| AR (1) | AR050931A1 (https=) |
| AT (1) | ATE402171T1 (https=) |
| AU (1) | AU2005284330B2 (https=) |
| BR (1) | BRPI0515259A (https=) |
| CA (1) | CA2577247C (https=) |
| DE (1) | DE602005008454D1 (https=) |
| DK (1) | DK1794152T3 (https=) |
| ES (1) | ES2249992B1 (https=) |
| MX (1) | MX2007002939A (https=) |
| NO (1) | NO20071817L (https=) |
| PA (1) | PA8645501A1 (https=) |
| PE (1) | PE20060720A1 (https=) |
| PL (1) | PL1794152T3 (https=) |
| PT (1) | PT1794152E (https=) |
| RU (1) | RU2413728C2 (https=) |
| TW (1) | TWI405760B (https=) |
| UY (1) | UY29115A1 (https=) |
| WO (1) | WO2006029811A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8635593B2 (en) * | 2008-05-13 | 2014-01-21 | Hewlett-Packard Development Company, L.P. | Dynamic autocompletion tool |
| CN112595803A (zh) * | 2020-12-31 | 2021-04-02 | 海南海神同洲制药有限公司 | 一种硝酸舍他康唑乳膏的鉴别方法 |
| CN113501815A (zh) * | 2021-07-30 | 2021-10-15 | 海南海神同洲制药有限公司 | 一种硝酸舍他康唑晶型的制备方法 |
| CN113501814A (zh) * | 2021-07-30 | 2021-10-15 | 海南海神同洲制药有限公司 | 一种硝酸舍他康唑的纯化方法 |
| CN113480517B (zh) * | 2021-07-30 | 2022-09-09 | 海南海神同洲制药有限公司 | 3-溴甲基-7-氯苯并[b]噻吩的合成方法 |
| CN113816947A (zh) * | 2021-08-25 | 2021-12-21 | 海南海神同洲制药有限公司 | 一种硝酸舍他康唑的重结晶方法 |
| CN113735843B (zh) * | 2021-09-07 | 2023-05-26 | 海南海神同洲制药有限公司 | 一种低熔点硝酸舍他康唑的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1096361B (it) * | 1978-05-18 | 1985-08-26 | Recordati Chem Pharm | Dibenzileteri sostituiti terapeuticamente attivi |
| JPS57169466A (en) * | 1981-04-14 | 1982-10-19 | Ota Seiyaku Kk | Preparation of imidazole derivative |
| CA1250586A (en) | 1984-02-02 | 1989-02-28 | Manuel Raga | 1h-imidazole derivatives and process for their production |
| US5135943A (en) * | 1984-02-02 | 1992-08-04 | Ferrer Internacional S.A. | 1H-imidazole derivative compounds and pharmaceutical compositions containing the same |
| ES529608A0 (es) * | 1984-02-02 | 1985-05-01 | Ferrer Int | Procedimiento de obtencion de nuevos derivados de 1h-imidazol |
| WO1996020939A1 (es) * | 1995-01-04 | 1996-07-11 | Ferrer Internacional, S.A. | POLYMORFOS B Y C DE MONONITRATO DE 1-[2,4-DICLORO-β-[(7-CLOROBENZO[b]TIEN-3-IL)METOXI]FENETIL]IMIDAZOL |
| HUP0104657A3 (en) * | 1998-12-24 | 2002-07-29 | Astellas Pharma Inc Chuo Ku | Imidazole compounds and pharmaceutical compositions containing them |
| CN1191250C (zh) * | 2001-09-26 | 2005-03-02 | 河北省药物研究所 | 一种硝酸舍他康唑的合成方法 |
| ES2203316B1 (es) * | 2002-02-11 | 2005-03-01 | Ferrer Internacional, S.A. | R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol. |
-
2004
- 2004-09-13 ES ES200402184A patent/ES2249992B1/es not_active Expired - Fee Related
-
2005
- 2005-09-09 PE PE2005001047A patent/PE20060720A1/es not_active Application Discontinuation
- 2005-09-12 PA PA20058645501A patent/PA8645501A1/es unknown
- 2005-09-12 AR ARP050103794A patent/AR050931A1/es not_active Application Discontinuation
- 2005-09-13 WO PCT/EP2005/009824 patent/WO2006029811A1/en not_active Ceased
- 2005-09-13 KR KR1020077005699A patent/KR100903922B1/ko not_active Expired - Fee Related
- 2005-09-13 DE DE602005008454T patent/DE602005008454D1/de not_active Expired - Lifetime
- 2005-09-13 EP EP05799300A patent/EP1794152B1/en not_active Expired - Lifetime
- 2005-09-13 JP JP2007530669A patent/JP5048500B2/ja not_active Expired - Fee Related
- 2005-09-13 AT AT05799300T patent/ATE402171T1/de active
- 2005-09-13 CA CA2577247A patent/CA2577247C/en not_active Expired - Fee Related
- 2005-09-13 PL PL05799300T patent/PL1794152T3/pl unknown
- 2005-09-13 RU RU2007113921/04A patent/RU2413728C2/ru not_active IP Right Cessation
- 2005-09-13 BR BRPI0515259-3A patent/BRPI0515259A/pt active Search and Examination
- 2005-09-13 UY UY29115A patent/UY29115A1/es unknown
- 2005-09-13 PT PT05799300T patent/PT1794152E/pt unknown
- 2005-09-13 MX MX2007002939A patent/MX2007002939A/es active IP Right Grant
- 2005-09-13 CN CN2005800306783A patent/CN101023077B/zh not_active Expired - Fee Related
- 2005-09-13 DK DK05799300T patent/DK1794152T3/da active
- 2005-09-13 AU AU2005284330A patent/AU2005284330B2/en not_active Ceased
- 2005-09-13 US US11/662,255 patent/US7626038B2/en not_active Expired - Fee Related
- 2005-09-13 TW TW094131395A patent/TWI405760B/zh not_active IP Right Cessation
-
2007
- 2007-04-04 NO NO20071817A patent/NO20071817L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7626038B2 (en) | 2009-12-01 |
| TWI405760B (zh) | 2013-08-21 |
| BRPI0515259A (pt) | 2008-07-15 |
| KR20070042206A (ko) | 2007-04-20 |
| CN101023077A (zh) | 2007-08-22 |
| MX2007002939A (es) | 2007-04-27 |
| AU2005284330A1 (en) | 2006-03-23 |
| AU2005284330B2 (en) | 2011-01-06 |
| ES2249992B1 (es) | 2007-03-01 |
| RU2413728C2 (ru) | 2011-03-10 |
| AR050931A1 (es) | 2006-12-06 |
| TW200621756A (en) | 2006-07-01 |
| PT1794152E (pt) | 2008-10-24 |
| PE20060720A1 (es) | 2006-07-11 |
| DK1794152T3 (da) | 2008-11-17 |
| WO2006029811A1 (en) | 2006-03-23 |
| KR100903922B1 (ko) | 2009-06-19 |
| PL1794152T3 (pl) | 2008-12-31 |
| EP1794152B1 (en) | 2008-07-23 |
| CA2577247C (en) | 2011-07-05 |
| EP1794152A1 (en) | 2007-06-13 |
| RU2007113921A (ru) | 2008-10-20 |
| JP2008512421A (ja) | 2008-04-24 |
| HK1105416A1 (en) | 2008-02-15 |
| DE602005008454D1 (de) | 2008-09-04 |
| PA8645501A1 (es) | 2006-05-16 |
| CA2577247A1 (en) | 2006-03-23 |
| US20080108682A1 (en) | 2008-05-08 |
| CN101023077B (zh) | 2012-05-23 |
| NO20071817L (no) | 2007-05-16 |
| JP5048500B2 (ja) | 2012-10-17 |
| ES2249992A1 (es) | 2006-04-01 |
| ATE402171T1 (de) | 2008-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Borisa et al. | A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies | |
| CR10125A (es) | Compuestos de azaindol inhibidores de aurora quinasas | |
| WO2007018314A3 (en) | Therapeutic agent for diabetes | |
| SV2006002187A (es) | Indazoles utiles para tratamientos de enfermedades cardiovasculares ref.wyth0089-504(am101590) | |
| GT200300289A (es) | Derivados de pirrolopirimidina | |
| ECSP105178A (es) | Compuestos de aril urea en combinación con otros agentes citostáticos o citotóxicos para el tratamiento de cáncer en humanos | |
| WO2008084223A3 (en) | Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors | |
| PA8680701A1 (es) | Derivados de oxindol | |
| DE502004002801D1 (de) | Bohrlochbehandlungsmittel, enthaltend ethercarbonsäuren | |
| AR094376A2 (es) | Proceso de producción de un compuesto orgánico | |
| WO2009001060A3 (en) | Use of compounds for preparing anti-tuberculosis agents | |
| CL2011000739A1 (es) | Un compuesto 3,5-bis(3,4-dihidroxifenil)-1,2,4-triazol; composición farmacéutica que lo comprende, útil para el tratamiento de enfermedades causadas por un beta-amiloide o una sinucleinopatia, tal como enfermedad de alzheimer y enfermedad de parkinson. | |
| PE20180504A1 (es) | PROCESOS E INTERMEDIARIOS PARA LA PREPARACION DE {1-(ETILSULFONIL)-3-[4-(7H-PIRROLO[2,3-d]PIRIMIDIN-4-IL)-1H-PIRAZOL-1-IL]AZETIDIN-3-IL}ACETONITRILO | |
| UY29115A1 (es) | Un procedimiento para fabricar compuestos enantiomericos del imidazol | |
| CR11605A (es) | Tratamiento de plantas ornamentales | |
| NL1026203A1 (nl) | Verbindingen toepasbaar voor de behandeling van ziekten. | |
| PT2056805E (pt) | Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de reacção tecidular | |
| CL2024000990A1 (es) | Métodos y composiciones para el tratamiento de la enfermedad renal poliquística | |
| NL1028599A1 (nl) | Verbindingen voor de behandeling van ziekten. | |
| UY30675A1 (es) | Metodos para el tratamiento de la depresion | |
| CR8562A (es) | Procedimiento para la preparacion de compuestos de triazol sustituidos | |
| SE0702509L (sv) | En process för att forma stål | |
| ECSP066271A (es) | Un método para la preparación de mirtazapina enantioméricamente pura | |
| UY29116A1 (es) | Un procedimiento de fabricacion de compuestos imidazolicos, sus sales y sus pseudopolimorfos | |
| WO2007014051A3 (en) | Use of amylin and amylin agonists as cardioprotective or myoprotective agents |